130 related articles for article (PubMed ID: 2885865)
1. Rebound insomnia in neuroleptic drug withdrawal neurophysiologic characteristics.
van Sweden B
Pharmacopsychiatry; 1987 May; 20(3):116-9. PubMed ID: 2885865
[TBL] [Abstract][Full Text] [Related]
2. Rebound insomnia: duration of use and individual differences.
Merlotti L; Roehrs T; Zorick F; Roth T
J Clin Psychopharmacol; 1991 Dec; 11(6):368-73. PubMed ID: 1770156
[TBL] [Abstract][Full Text] [Related]
3. Zopiclone discontinuation: review of 25 studies assessing withdrawal and rebound phenomena.
Bianchi M; Musch B
Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():139-45. PubMed ID: 2387981
[No Abstract] [Full Text] [Related]
4. Rebound insomnia: a critical review.
Gillin JC; Spinweber CL; Johnson LC
J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
[TBL] [Abstract][Full Text] [Related]
5. The utilization of hypnotics in chronic schizophrenics: some critical remarks.
Jus K; Jus A; Villeneuve A; Pires P; Fontaine P
Biol Psychiatry; 1979 Dec; 14(6):955-60. PubMed ID: 41605
[TBL] [Abstract][Full Text] [Related]
6. Long term efficacy and withdrawal of zopiclone: a sleep laboratory study.
Pecknold J; Wilson R; le Morvan P
Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():57-67. PubMed ID: 2117623
[TBL] [Abstract][Full Text] [Related]
7. Rebound insomnia after abrupt clozapine withdrawal.
Staedt J; Stoppe G; Hajak G; Ruther E
Eur Arch Psychiatry Clin Neurosci; 1996; 246(2):79-82. PubMed ID: 9063912
[TBL] [Abstract][Full Text] [Related]
8. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
Lemoine P; Nir T; Laudon M; Zisapel N
J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
[TBL] [Abstract][Full Text] [Related]
9. Withdrawal from clozapine: the "rebound phenomenon".
Durst R; Teitelbaum A; Katz G; Knobler HY
Isr J Psychiatry Relat Sci; 1999; 36(2):122-8. PubMed ID: 10472746
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
Chouinard G; Bradwejn J; Annable L; Jones BD; Ross-Chouinard A
J Clin Psychiatry; 1984 Dec; 45(12):500-2. PubMed ID: 6150030
[TBL] [Abstract][Full Text] [Related]
11. Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.
Bhanji NH; Chouinard G; Kolivakis T; Margolese HC
Can J Clin Pharmacol; 2006; 13(1):e69-74. PubMed ID: 16456219
[TBL] [Abstract][Full Text] [Related]
12. Subjective effects during administration and on discontinuation of zopiclone and temazepam in normal subjects.
Lader M; Frcka G
Pharmacopsychiatry; 1987 Mar; 20(2):67-71. PubMed ID: 2884682
[TBL] [Abstract][Full Text] [Related]
13. Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats.
Hirase M; Ishida T; Kamei C
Eur J Pharmacol; 2008 Nov; 597(1-3):46-50. PubMed ID: 18789918
[TBL] [Abstract][Full Text] [Related]
14. REM-latency in neuroleptic drug withdrawal. A case report.
Van Sweden B
Acta Psychiatr Belg; 1984; 84(3):235-9. PubMed ID: 6148841
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
Small GW; Bystritsky A
J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
[TBL] [Abstract][Full Text] [Related]
16. Thioridazine withdrawal-induced behavioral deterioration treated with clonidine: two case reports.
Sovner R
Ment Retard; 1995 Aug; 33(4):221-5. PubMed ID: 7565144
[TBL] [Abstract][Full Text] [Related]
17. [The risk of neuroleptic discontinuation in schizophrenia].
Jarema M
Psychiatr Pol; 1999; 33(1):69-81. PubMed ID: 10786216
[TBL] [Abstract][Full Text] [Related]
18. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
[TBL] [Abstract][Full Text] [Related]
19. Developing new neuropsychotropic drugs--focus on hypnotics.
Koella WP
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):623-9. PubMed ID: 6131494
[No Abstract] [Full Text] [Related]
20. Neuroleptic withdrawal with remitted schizophrenics: a naturalistic follow-up study.
Nishikawa T; Hayashi T; Koga I; Uchida Y
Psychiatry; 2007; 70(1):68-79. PubMed ID: 17492913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
